Evidence map›Paper›PMID 40359163›Full record

ArticleJournal of industrial microbiology & biotechnology2024

Microbial biosynthesis of rare cannabinoids.

Chunsheng Yan, Ikechukwu C Okorafor, Colin W Johnson, Kendall N Houk, Neil K Garg, Yi Tang

Abstract read
In one paragraph

Article in Journal of industrial microbiology & biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chunsheng YanDepartment of Chemical and Biomolecular Engineering, University of California, Los Angeles, CA 90095, USA.
Ikechukwu C OkoraforDepartment of Chemical and Biomolecular Engineering, University of California, Los Angeles, CA 90095, USA.
Colin W JohnsonDepartment of Chemistry and Biochemistry, University of California, Los Angeles, CA 90095, USA.ORCID 0000-0003-1092-1172
Kendall N HoukDepartment of Chemistry and Biochemistry, University of California, Los Angeles, CA 90095, USA.
Neil K GargDepartment of Chemistry and Biochemistry, University of California, Los Angeles, CA 90095, USA.
Yi TangDepartment of Chemical and Biomolecular Engineering, University of California, Los Angeles, CA 90095, USA.ORCID 0000-0003-1597-0141

Funding

Engineering Yeast towards High Titer Production of Monoterpene Indole Alkaloid Natural ProductsR01AT010001 · NCCIH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Dino Di Carlo, Yi Tang · 2018 to 2026
$3.6M
Chemistry Biology Interface Training ProgramT32GM136614 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Patrick G. Harran · 2020 to 2026
$2.8M
Time-of-Flight Mass Spectrometer for Synthesis Supporting Biomedical ResearchS10RR025631 · NCRR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HOUK, KENDALL N · 2009 to 2009
$328k
California Department of Cannabis Control 93414NCCIH NIH HHS R01 AT010001NCRR NIH HHS S10 RR025631NIGMS NIH HHS 5T32GM136614NIGMS NIH HHS T32 GM136614NIH HHS S10RR025631NSF CHE-1048804
6 · The paper itself

Abstract

∆9-tetrahydrocannabinol (∆9-THC) and cannabidiol are the most abundant natural cannabinoids isolated from the different cultivars of the Cannabis plant. Other natural ∆9-THC analogs, especially those with different alkyl chain substitutions, display different and potent bioactivity. However, these rare cannabinoids are typically isolated in minuscule amounts and are difficult to synthesize. Targeted microbial biosynthesis can therefore be an attractive route to access such molecules. Here, we report the development of a Saccharomyces cerevisiae host to biosynthesize 2 rare cannabinoids from simple sugars. The yeast host is engineered to accumulate excess geranyl pyrophosphate, to overexpress a fungal pathway to 2,4-dihydroxy-6-alkyl-benzoic acids, as well as the downstream UbiA-prenyltransferase and ∆9-tetrahydrocannabinolic acid synthase. Two rare cannabinoid acids, the C1-substituted ∆9-tetrahydrocannabiorcolic acid (∼16 mg/L) and the C7-substituted ∆9-tetrahydrocannabiphorolic acid (∼5 mg/L) were obtained from this host; the latter was thermally decarboxylated to give ∆9-tetrahydrocannabiphorol. Given the diversity of fungal biosynthetic gene clusters that can produce resorcylic acids, this microbial platform offers the potential to produce other rare and new-to-nature cannabinoids. One Sentence Summary:  Saccharomyces cerevisiae as a host to produce rare cannabinoids.

Indexed as

CannabinoidsSaccharomyces cerevisiaeBiosynthetic PathwaysCannabisMetabolic EngineeringPolyisoprenyl PhosphatesCannabinoidsgeranyl pyrophosphatePolyisoprenyl PhosphatesCannabinoidsNatural productPolyketidePrenyltransferaseYeast

Identifiers

PMID40359163
PMCPMC12134893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.